The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat

Experimental Biology and Medicine

Volumn 233, Issue 11, 2008, Pages 1385-1388

  Hauso, Øyvind ^a   Gustafsson, Björn I ^a,b   Nordrum, Ivar S ^c,d   Waldum, Helge L ^a,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

5 ht receptors; Fibrosis; Liver; Serotonin; Terguride

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; HYALURONIC ACID; HYDROXYPROLINE; TERGURIDE; ACTIN; DRUG DERIVATIVE; LISURIDE; SEROTONIN ANTAGONIST; SMOOTH MUSCLE ACTIN, RAT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG SCREENING; FATTY LIVER; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER WEIGHT; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; ANIMAL; BLOOD ANALYSIS; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL LIVER CIRRHOSIS; LIVER; ORGAN SIZE; PATHOLOGY;

ANIMALIA; RATTUS;

ACTINS; ANIMALS; BLOOD CHEMICAL ANALYSIS; CARBON TETRACHLORIDE; FEMALE; IMMUNOHISTOCHEMISTRY; LISURIDE; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS;

EID: 58249083070     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0804-RM-137     Document Type: Article

References (14)

1. Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14:618-633, 1999.
2. Mann DA, Smart DE. Transcriptional regulation of hepatic stellate cell activation. Gut 50:891-896, 2002.
3. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250, 2000.
4. Beaudry P, Hadengue A, Callebert J, Gaudin C, Soliman H, Moreau R, Launay JM, Lebrec D. Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology 20:800-803, 1994.
5. Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 169:861-876, 2006.
6. Li T, Weng SG, Leng XS, Peng JR, Wei YH, Mou DC, Wang WX. Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells. Hepatobiliary Pancreat Dis Int 5:96-100, 2006.
7. Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/al-pha(2)-adrenoceptor. J Pharmacol Exp Ther 303:805-814, 2002.
8. Jahnichen S, Horowski R, Pertz HH. Agonism at 5-HT2B receptors is not a class effect of the ergolines. Eur J Pharmacol 513:225-228, 2005.
9. Hauso O, Gustafsson BI, Loennechen JP, Stunes AK, Nordrum I, Waldum HL. Long-term serotonin effects in the rat are prevented by terguride. Regul Pept 143:39-46, 2007.
10. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 117:237-250, 2005.
11. Fossmark R, Zhao CM, Martinsen TC, Kawase S, Chen D, Waldum HL. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats. APMIS 113:436-449, 2005.
12. Woessner JF Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 93:440-447, 1961.
13. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88:125-172, 2008.
14. Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol 99:2466-2478, 2004.